secwatch.observer — SEC 8-K summary
======================================

Issuer:     Acer Therapeutics Inc. (—)
CIK:        0001069308
Form:       8-K
Filed at:   2023-05-04T23:59:59+00:00
Accession:  0000950170-23-017313
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Acer Therapeutics receives Nasdaq delisting notice for MVLS below $35M; 180-day compliance period
--------------------------------------------------------------------------------

- Nasdaq notified Acer on May 3, 2023 that MVLS was below $35M for 30 consecutive business days, violating rule 5550(b)(2).
- Company has until October 30, 2023 to regain compliance by achieving MVLS ≥ $35M for 10 consecutive trading days.
- Alternatively, Acer can regain compliance by maintaining minimum stockholders' equity of $2.5 million.
- If compliance not regained, Nasdaq may delist shares; company can appeal to a Hearings Panel.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1069308/000095017023017313/0000950170-23-017313-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1069308/000095017023017313/acer-20230503.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-017313

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer